Clinical Trial

Oral Microbiota and Muscle Function in the Ageing Subject

Study acronym: MYOBIOTA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Ageing of the general population may be a risk factor for various complications, including sarcopenia. Sarcopenia is a progressive loss of muscle mass and muscle strength, leading to a decrease in functional capacities. It affects between 0.7% and 16% of European adults over 70 years of age (1). Recent studies suggest that the faecal microbiota may be altered with ageing but also according to sarcopenic status. Furthermore, no study has currently published data on the relationship between salivary microbiota and sarcopenic status. The main hypothesis of this study is that a decrease in salivary microbiota richness could be associated with impaired handgrip strength in the ageing subject.
Trial Details
NCT Number NCT07687511
Lead Sponsor University Hospital, Rouen
Conditions Non-hospitalised Men and Women Over 70 Years of Age
Enrollment 60 participants
Start Date 2026-07
Primary Completion 2028-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-07